SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-312316
Filing Date
2014-08-18
Accepted
2014-08-18 06:05:07
Documents
3
Period of Report
2014-08-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d775913d8k.htm 8-K 29173
2 EX-3.1 d775913dex31.htm EX-3.1 24097
3 EX-4.1 d775913dex41.htm EX-4.1 261299
  Complete submission text file 0001193125-14-312316.txt   315868
Mailing Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044
Business Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044 602-910-2617
Insys Therapeutics, Inc. (Filer) CIK: 0001516479 (see all company filings)

IRS No.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35902 | Film No.: 141047850
SIC: 2834 Pharmaceutical Preparations